This Bear Market Could Be the Best Investing Opportunity in More Than a DecadeThe Motley Fool • 10/29/22
Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Surpass EstimatesZacks Investment Research • 10/27/22
Vertex Pharmaceuticals Jumps After Quarterly Beat, Raises 2022 OutlookInvestors Business Daily • 10/27/22
Which Stocks Are Most Likely to Thrive in a Recession? Here's What History ShowsThe Motley Fool • 10/23/22
CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?Investors Business Daily • 10/20/22